Zanamivir

Relenza

Bibliografia - Quali fonti bibliografiche per Zanamivir?

1. Australian Adverse Drug Reaction Bullettin, 2000, 19, 6.


2. Beigel J.H. et al., NEJM, 2005, 353, 1374.


3. Burls A. et al., Supplement to the Assessment Report, 2000, http://www.nice.org.uk


4. De Jong M.T. et al., NEJM, 2005, 353, 2667.


5. Gubareva L.V. et al., 1998, 178, 1257.


6. Hayden F.G. et al., Antiviral. Res., 1994, 25, 123.


7. Hayden F.G. et al., JAMA, 1996, 275, 295.


8. Hayden F.G. et al., NEJM, 1997, 337, 874.


9. Hayden F.G. et al., Antivir. Ther., 2005, 10, 873.


10. Hatakeyama S. et al., JAMA, 2007, 297, 1435.


11. Hussey E. et al., 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995, 17-20 settembre, San Francisco.


12. Ison M.G. et al., J. Infect. Dis., 2006, 193, 760.


13. Kaiser L. et al., Arch. Intern. Med., 2000, 160, 3234.


14. Kaiser L. et al., Arch. Intern. Med., 2003, 163, 1667.


15. Lancet, 1998, 352, 1877.


16. Madren L.K. et al., Antiviral Chem. Chemother., 1995, 6, 109.


17. Monto A.S. et al., JAMA, 1999, 282, 31.


18. Murphy K.R. et al., Clin. Drug Invest., 2000, 20, 337.


19. Neuraminidase inhibitors for treatment of influenza A and B infections, MMWR Morb. Mortal Wkly Rep., 1999, 48 (RR-14), 1.


20. Neuraminidase Inhibitor Susceptibility Network, Wkly Epidemiol. Rec., 2007, 17, 149.


21. NICE, review of existing guidance, 2009, N. 58, http://www.nice.org.uk


22. Ong A.K., Hayden F.G., J. Infect. Dis., 2007, 196, 181.


23. Peterson M.C. et al., Pharm. Res., 1996, 13 Suppl., 448.


24. Van der Vries et al., NEJM, 2008, 359, 1074.


25. Williamson J.C., Pegram P.S., NEJM, 2000, 342 (9).


26. Williamson J.C., Pegram P.S., Am. J. Respir. Med., 2002, 1, 85.


27. Woods J.M. et al., Antimicrob. Agents Chemother., 1993, 37, 1473.

Link

BMJ, British Medical Journal
http://www.bmj.com

Articoli di ultima pubblicazione dedicati ad zanamivir:
“Neuroaminidase inibitors for treatment and prophylaxis of influenza in children: sistematic review and metanalysis of randomised controlled trials” BMJ, 2009, 339, b3172

JAMA, Journal American Medical Association
http://jama.ama-assn.org/

Articoli di ultima pubblicazione dedicati ad zanamivir:
“Neurologic Complications Associated With Novel Influenza A (H1N1) Virus Infection in Children - Dallas, Texas, May 2009”, JAMA, October 28, 2009, 302, 1746 - 1748.
“Novel Influenza A (H1N1) Virus Infections in Three Pregnant Women- United States, April-May 2009”, JAMA, July 1, 2009, 302, 23 - 25.

NEJM, New England Journal Medicine
http://www.content.nejm.org

Articoli di ultima pubblicazione dedicati ad zanamivir:
“Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009”
“Prevention and Treatment of Seasonal Influenza”
“Update on Avian Influenza A (H5N1) Virus Infection in Humans”

The Lancet http://www.thelancet.com

Articoli di ultima pubblicazione dedicati ad zanamivir:
“Prescription of anti-influenza drugs for healty adults: a sistemic review and meta-analysis” The Lancet Infection Disease, 2009, 9 (9), 537-545